the influence of verapamil , a calcium antagonist , on circulating levels of glucose , insulin and glucagon has been evaluated in 5 normal subjects and in 5 patients with non insulin-dependent diabetes ( niddm ) .
C0021641
insulin
C0011860
non insulin-dependent diabetes